Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma

NCT06871007 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ENROLLING_BY_INVITATION

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Primary Mediastinal (Thymic) Large B-cell Lymphoma
Children
Nivolumab

Interventions

DRUG: Nivolumab

Sponsor

St. Petersburg State Pavlov Medical University